Cutimed® Epiona®

is a sterile, collagen alginate dressing consisting of 90% native bovine collagen and 10% calcium alginate. The collagen fibers utilize an open-pore 3D Matrix™  Technology with a unique similarity to human dermis. This structure acts as a scaffold that boosts wound healing for wounds that have stalled or have not progressed towards a healing goal.

  • Stimulates tissue growth
  • Promotes wound healing
  • Easy application

Intended Purpose

Indications: Cutimed® Epiona® is indicated for the management of full and partial thickness wounds which are free of necrotic tissue, e.g.: diabetic ulcers, venous leg ulcers, pressure injuries, ulcers caused by mixed vascular etiologies, trauma wounds and surgical wounds.

Wear time: The biologically degradable Cutimed® Epiona® will be absorbed naturally by the body. After first application, the wound should be treated at intervals of up to 72 hours, depending on the amount of exudate. Cutimed® Epiona® matrix which has not been absorbed by the body can remain in the wound. 

Learn about the product and how to apply it

This video shows how Cutimed Epiona supports and facilitates the healing of chronic and stagnating wounds and can be used for superficial and deep wounds.

Learn about the product's mode of action

This video shows how Cutimed Epiona supports and facilitates the healing of chronic and stagnating wounds and can be used for superficial and deep wounds.

Product benefits

Symbol with three dynamic arrows to visualize that the product stimulates wound healing

Stimulates tissue growth

Boosts wound healing in chronic and stagnating wounds and reduces wound size by up to 38%.1, 2
Symbol of a happy person on a sunny day to represent increasing quality of life

Promotes wound healing

Accelerates wound healing, contributing to early patient mobilization and reduced treatment time.1, 3

Easy application

Can be cut to size, rolled or folded into the wound bed. If required, several layers can be used. Both-side application possible. 

 Helps to stop bleeding

Contains native collagen and calcium alginate that supports haemostasis.

Product facts

Superficial and deep

Granulating

Epithelialising

Low to moderate

Secondary dressing needed

Both side application

How to use

Image showing how to apply Cutimed® Epiona®
1. Prior to treatment with Cutimed® Epiona®, dry and necrotic tissue has to be removed.
2. After carrying out an enzymatic debridement, the wound should be cleaned carefully with a sterile physiological saline or Ringers‘ solution before Cutimed® Epiona® is applied.
3. To achieve an optimal effect, Cutimed® Epiona® should be applied directly to the entire wound bed.
4. In wounds with little or no exudate, Cutimed® Epiona® should be moistened with a saline solution or Ringer‘s solution.
5. The biologically degradable Cutimed® Epiona® will be absorbed naturally by the body.
6. Cutimed® Epiona® dressing must be covered with an appropriate secondary dressing in order to maintain a moist wound environment.
7. After first application, the wound should be treated at intervals of up to 72 hours, depending on the amount of exudate. Cutimed® Epiona® matrix which has not been absorbed by the body can remain in the wound.

Product specifications

PRODUCT
REF
Dimensions
Pieces/box
Cutimed® Epiona® 7322700 2 in x 2 in 10
Cutimed® Epiona® 7322702 8 in x 8 in 10
Cutimed® Epiona® 7322704 4 in x 4 in 10

Supporting products

Cutimed® Siltec®

is a silicone coated, sterile, absorbent polyurethane foam dressing with superabsorbent stripes to additionally absorb and lock wound exudate. The wound contact surface allows adherence to the periwound skin but not to the moist wound bed or newly formed epithelial tissue.

Cutimed® Siltec® B

is a bordered, silicone coated, sterile, absorbent polyurethane foam dressing

Medical References

1 Sabo M et. al. A Post-marketing Surveillance Study of Chronic Wounds Treated With a Native Collagen Calcium Alginate Dressing. Ostomy Wound Manage. 2018; 64:38-43.
2 Wiegand C et al. A novel native collagen dressing with advantageous properties to promote physiological wound healing. J Wound Care. 2016;25:713-720.
3 Oropallo A et al. Improving Quality of Life in the Treatment of Chronic Venous Leg Ulcers. EWMA, October, 26-27, 2021, EWMA Virtual Conference.